Effect of salmeterol/fluticasone combination on the dynamic changes of lung mechanics in mechanically ventilated COPD patients: a prospective pilot study

Int J Chron Obstruct Pulmon Dis. 2016 Jan 27:11:167-74. doi: 10.2147/COPD.S94709. eCollection 2016.

Abstract

Background: The combined therapy of inhaled corticosteroids and long-acting beta-2 agonists for mechanically ventilated patients with COPD has never been explored. Therefore, the aim of this study was to investigate their dynamic effects on lung mechanics and gas exchange.

Materials and methods: Ten mechanically ventilated patients with resolution of the causes of acute exacerbations of COPD were included. Four puffs of salmeterol 25 μg/fluticasone 125 μg combination therapy were administered. Lung mechanics, including maximum resistance of the respiratory system (Rrs), end-inspiratory static compliance, peak inspiratory pressure (PIP), plateau pressure, and mean airway pressure along with gas exchange function were measured and analyzed.

Results: Salmeterol/fluticasone produced a significant improvement in Rrs and PIP after 30 minutes. With regard to changes in baseline values, salmeterol/fluticasone inhalation had a greater effect on PIP than Rrs. However, the therapeutic effects seemed to lose significance after 3 hours of inhaled corticosteroid/long-acting beta-2 agonist administration.

Conclusion: The combination of salmeterol/fluticasone-inhaled therapy in mechanically ventilated patients with COPD had a significant benefit in reducing Rrs and PIP.

Keywords: COPD; inhaled corticosteroid; long-acting beta-2 agonist; mechanical ventilation; respiratory failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Aged
  • Aged, 80 and over
  • Bronchodilator Agents / administration & dosage
  • Drug Monitoring / methods
  • Female
  • Fluticasone-Salmeterol Drug Combination / administration & dosage
  • Humans
  • Lung* / drug effects
  • Lung* / physiopathology
  • Male
  • Pilot Projects
  • Prospective Studies
  • Pulmonary Disease, Chronic Obstructive* / diagnosis
  • Pulmonary Disease, Chronic Obstructive* / physiopathology
  • Pulmonary Disease, Chronic Obstructive* / therapy
  • Respiration, Artificial / methods*
  • Respiratory Function Tests / methods
  • Taiwan
  • Treatment Outcome

Substances

  • Bronchodilator Agents
  • Fluticasone-Salmeterol Drug Combination